Company / CapEx per Share
Mineralys Therapeutics, Inc. CapEx per Share History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.00
FY2024
5-year range
$0.00 / $0.00
FY2023-FY2024
Trend
-
vs FY2023
Sector context
#164 of 192
Health Care
What the data says
Mineralys Therapeutics, Inc.'s capex per share of $0.00 is lower than 85% of companies in the Health Care sector (FY2024).
Based on SEC 10-K filings.
0.00 in FY2024.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 15% in Health CareTop 85% of 192This company $0.00 Sector average $3.54
▼
-99.9% below sector average
Key checks
Key Insights
- Ranks #164 out of 192 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.00 | - |
| FY2023 | $0.00 | - |
| FY2022 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026